Growth hormone, IGF-I and diabetic angiopathy revisited

Clinical Endocrinology

Volumn 52, Issue 1, 2000, Pages 11-12

  Møller, Niels ^a   Ørskov, Hans ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

DIABETIC ANGIOPATHY; GROWTH HORMONE RELEASE; HORMONE ACTION; HUMAN; HYPOPHYSECTOMY; NEOVASCULARIZATION (PATHOLOGY); NOTE; PRIORITY JOURNAL; RETINOPATHY;

EID: 0033982471     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.00925.x     Document Type: Note

References (8)

1. 1 Alzaid, A.A., Dinneen, S.F., Melton, L.J., Rizza, R. (1994) The role of growth hormone in the developmemt of diabetic retinopathy. Diabetes Care, 17, 531 531.
2. 2 Amiel, S.A., Sherwin, R.S., Hintz, R.L., Gertner, J.M., Press, C.M., Tamborlane, W.V. (1984) Effect of diabetes and its control on insulin‐like growth factors in the young subject with type 1 diabetes mellitus. Diabetes, 33, 1175 1179.
3. 3 Dill, D.G., Moss, S.E., Klein, R., Klein, B.E. (1991) Association of elevated IGF‐I levels with increased retinopathy in late‐onset diabetes. Diabetes, 40, 1725 1730.
4. 4 Flyvbjerg, A., Bennett, W.F., Rasch, R., Kopschick, J.J., Scarlett, J.A. (1999) Inhibitory effect of a growth hormone receptor antagonist (G120K–PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice. Diabetes, 48, 377 382.
5. 5 Janssen, J.A.M.J.L. & Lamberts, S.W.J. (2000) Circulating IGF‐1 and its protective role in the pathogenesis of diabetic angiopathy. Clinical Endocrinology, 52, 1 9.
6. 6 Klein, R., Klein, B.E., Moss, S.E., Cruickshanks, K.J. (1994) The Wisconsin Epidemiologic Study of diabetic retinopathy XIV. Ten‐year incidence and progression of diabetic retinopathy. Archives of Ophthalmology, 112, 1217 1228.
7. 7 Lundbaek, K., Jensen, V.A., Olsen, S.T., Ørskov, H., Christensen, N.J., Hansen, A.P., Østerby, R. (1970) Diabetes, diabetic angiopathy and growth hormone. Lancet, II, 131 133.
8. 8 Sharp, P.S., Fallon, T.J., Brazier, O.J., Sandler, L., Joplin, G.F., Kohner, E.M. (1987) Long‐term follow‐up of patients who underwent yttrium‐90 pituitary implantation for treatment of proliferative diabetic retinopathy. Diabetologia, 30, 199 207.